1
|
Tratrat C. 1,2,4-Triazole: A Privileged Scaffold for the Development of Potent Antifungal Agents - A Brief Review. Curr Top Med Chem 2021; 20:2235-2258. [PMID: 32621720 DOI: 10.2174/1568026620666200704140107] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Revised: 03/04/2020] [Accepted: 04/13/2020] [Indexed: 12/23/2022]
Abstract
Over the past decades, a tremendous rise in invasive fungal infection diseases attributed to the yeast Candida albicans in immunocompromised individuals poses a seriously challenging issue. Another concern is the emergence of multi-drug resistant pathogens to the existing medicines due to their overuse and misuse. It was recently reported that 25-55% of the mortality rate is caused by invasive infection. Despite a large variety of drugs being available to treat invasive candidiasis, only two of them contain a 1,2,4-triazole core, namely Fluconazole and itraconazole, which are efficient in treating infection induced by fungal Candida species. Moreover, long-term therapy associated with azole medications has led to an increase in azole resistance as well as a high risk of toxicity. Despite numerous outstanding achievements in antifungal drug discovery, development of novel, safer and potent antifungal agents while overcoming the resistance problem associated with the current drugs is becoming the main focus of medicinal chemists. Therefore, this review outlines the breakthroughs in medicinal chemistry research regarding 1,2,4- triazole-based derivatives as potential antifungal agents in the past decade. In addition, the structureactivity relationship of these compounds is also discussed.
Collapse
Affiliation(s)
- Christophe Tratrat
- Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia
| |
Collapse
|
2
|
Han X, Wang S, Zhang N, Ren L, Sun X, Song Y, Wang J, Xiao B. Novel Triazole Derivatives Containing Different Ester Skeleton: Design, Synthesis, Biological Evaluation and Molecular Docking. Chem Pharm Bull (Tokyo) 2019; 68:64-69. [PMID: 31708557 DOI: 10.1248/cpb.c19-00624] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Invasive fungal disease constitutes a growing health problem and development of novel antifungal drugs with high potency and selectivity are in an urgent need. In this study, a novel series of triazole derivatives containing different ester skeleton were designed and synthesized. Microdilution broth method was used to investigate antifungal activity. Significant inhibitory activity of compounds 5c, 5d, 5e, 5f, 5m and 5n was evaluated against the Candida albicans (I), Candida albicans clinical isolate (II), Candida glabrata clinical isolate (I), and Candida glabrata (II) with minimum inhibitory concentrations (MIC80) values ranging from 2 to 16 µg/mL. Notably, compounds 5e and 5n showed the best inhibition against Candida albicans (II), Candida glabrata (I), and Candida glabrata (II) at the concentrations of 2 and 8 µg/mL, respectively. Molecular docking study revealed that the target compounds interacted with CYP51 mainly through hydrophobic and van der Waals interactions. The results indicated that these novel triazole derivatives could serve as promising leads for development of antifungal agents.
Collapse
Affiliation(s)
- Xiaoyan Han
- Laboratory of Clinical Pharmacy, Ordos School of Clinical Medicine, Inner Mongolia Medical University
| | - Shumin Wang
- Laboratory of Clinical Pharmacy, Ordos School of Clinical Medicine, Inner Mongolia Medical University
| | - Na Zhang
- Laboratory of Clinical Pharmacy, Ordos School of Clinical Medicine, Inner Mongolia Medical University
| | - Liwen Ren
- Beijing Key Laboratory of Drug Target Identification, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College
| | - Xiaoyang Sun
- National Drug Clinical Trial Institution of CangZhou Central Hospital
| | - Yali Song
- Key Laboratory of Pharmaceutical Quality Control of Hebei Province, College of Pharmaceutical Sciences, Hebei University
| | - Jinhua Wang
- Beijing Key Laboratory of Drug Target Identification, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College
| | - Bin Xiao
- Laboratory of Clinical Pharmacy, Ordos School of Clinical Medicine, Inner Mongolia Medical University.,Beijing Key Laboratory of Drug Target Identification, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College
| |
Collapse
|
3
|
Amphiphilic silicone-bridged bis-triazoles as effective, selective metal ligands and biologically active agents in lipophilic environment. J Mol Liq 2019. [DOI: 10.1016/j.molliq.2019.111560] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
4
|
Utthra PP, Raman N. Probing the potency of triazole tethered Schiff base complexes and the effect of substituents on their biological attributes. Int J Biol Macromol 2018; 116:194-207. [DOI: 10.1016/j.ijbiomac.2018.05.009] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2018] [Revised: 04/21/2018] [Accepted: 05/02/2018] [Indexed: 01/14/2023]
|
5
|
Wu J, Ni T, Chai X, Wang T, Wang H, Chen J, Jin Y, Zhang D, Yu S, Jiang Y. Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives. Eur J Med Chem 2017; 143:1840-1846. [PMID: 29133044 DOI: 10.1016/j.ejmech.2017.10.081] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2017] [Revised: 10/24/2017] [Accepted: 10/30/2017] [Indexed: 01/28/2023]
Abstract
The incidence of life-threatening fungal infections has dramatically increased for decades. In order to develop novel antifungal agents, two series of (2R,3R)-1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-(N-substitutied)-2-butanols (3a-o, 5a-f, 8a-u), which were analogues of voriconazole, were designed, synthesized and characterized by 1H NMR, 13C NMR and HRMS. The MIC80 values showed that the target compounds 3a-o indicated better activities than fluconazole on three important fungal pathogens except for 3i. Significant activity of compounds 3d, 3k, 3n, 3m and 3o was observed on the Aspergillus fumigatus strain (MIC80 range: 1-0.125 μg/ml). Especially, compound 3k had strong activity to inhibit the growth of ten fungal pathogens. But it didn't exhibit good activity in in vivo value. Molecular docking experiments demonstrated that 3k possessed superior affinity with target enzyme by strong hydrogen bond from morpholine ring.
Collapse
Affiliation(s)
- Junqi Wu
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China; Student Bridge, Second Military Medical University, Shanghai 200433, China
| | - Tingjunhong Ni
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Xiaoyun Chai
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Ting Wang
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Hongrui Wang
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Jindong Chen
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Yongsheng Jin
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Dazhi Zhang
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Shichong Yu
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
| | - Yuanying Jiang
- Center for New Drug Research, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
| |
Collapse
|
6
|
Wang Y, Xu K, Bai G, Huang L, Wu Q, Pan W, Yu S. Synthesis and antifungal activity of novel triazole compounds containing piperazine moiety. Molecules 2014; 19:11333-40. [PMID: 25090121 PMCID: PMC6271785 DOI: 10.3390/molecules190811333] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2014] [Revised: 07/18/2014] [Accepted: 07/21/2014] [Indexed: 12/02/2022] Open
Abstract
Design and synthesis of triazole library antifungal agents having piperazine side chains, analogues to fluconazole were documented. The synthesis highlighted utilization of the click chemistry on the basis of the active site of the cytochrome P450 14α-demethylase (CYP51). Their structures were characterized by 1H-NMR, 13C-NMR, MS and IR. The influences of piperazine moiety on in vitro antifungal activities of all the target compounds were evaluated against eight human pathogenic fungi.
Collapse
Affiliation(s)
- Yanwei Wang
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, 325Guohe Road, Shanghai 200433, China
| | - Kehan Xu
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, 325Guohe Road, Shanghai 200433, China
| | - Guojing Bai
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, 325Guohe Road, Shanghai 200433, China
| | - Lei Huang
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, 325Guohe Road, Shanghai 200433, China
| | - Qiuye Wu
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, 325Guohe Road, Shanghai 200433, China
| | - Weihua Pan
- Shanghai Key Laboratory of Molecular Medical Mycology, Department of Dermatology, Shanghai Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai 200003, China.
| | - Shichong Yu
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, 325Guohe Road, Shanghai 200433, China.
| |
Collapse
|